Utility of antibiotic therapy in preterm premature rupture of membranes: A meta-analysis

Cande V. Ananth, Jeanne-Marie Guise, John M. Thorp

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The optimal management of preterm premature rupture of membranes (PROM) is controversial. Maternal risks must be weighed against fetal benefit when expectant management is considered. Despite concerns about maternal harm, protocols of expectant management seem to afford the best perinatal outcomes. Given that infection often is the common pathway for delivery in preterm PROM, recent reports have explored the utility of maternal administration of antibiotics. In this paper we will summarize these results using meta- analytic techniques and assess the impact of antibiotic therapy on maternal and perinatal outcomes.

Original languageEnglish (US)
Pages (from-to)324-328
Number of pages5
JournalObstetrical and Gynecological Survey
Volume51
Issue number5
DOIs
StatePublished - May 1996
Externally publishedYes

Fingerprint

Meta-Analysis
Mothers
Anti-Bacterial Agents
Therapeutics
Preterm Premature Rupture of the Membranes
Infection

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Utility of antibiotic therapy in preterm premature rupture of membranes : A meta-analysis. / Ananth, Cande V.; Guise, Jeanne-Marie; Thorp, John M.

In: Obstetrical and Gynecological Survey, Vol. 51, No. 5, 05.1996, p. 324-328.

Research output: Contribution to journalArticle

@article{b00ffbfc8d9e4c1386605f289913f59d,
title = "Utility of antibiotic therapy in preterm premature rupture of membranes: A meta-analysis",
abstract = "The optimal management of preterm premature rupture of membranes (PROM) is controversial. Maternal risks must be weighed against fetal benefit when expectant management is considered. Despite concerns about maternal harm, protocols of expectant management seem to afford the best perinatal outcomes. Given that infection often is the common pathway for delivery in preterm PROM, recent reports have explored the utility of maternal administration of antibiotics. In this paper we will summarize these results using meta- analytic techniques and assess the impact of antibiotic therapy on maternal and perinatal outcomes.",
author = "Ananth, {Cande V.} and Jeanne-Marie Guise and Thorp, {John M.}",
year = "1996",
month = "5",
doi = "10.1097/00006254-199605000-00024",
language = "English (US)",
volume = "51",
pages = "324--328",
journal = "Obstetrical and Gynecological Survey",
issn = "0029-7828",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Utility of antibiotic therapy in preterm premature rupture of membranes

T2 - A meta-analysis

AU - Ananth, Cande V.

AU - Guise, Jeanne-Marie

AU - Thorp, John M.

PY - 1996/5

Y1 - 1996/5

N2 - The optimal management of preterm premature rupture of membranes (PROM) is controversial. Maternal risks must be weighed against fetal benefit when expectant management is considered. Despite concerns about maternal harm, protocols of expectant management seem to afford the best perinatal outcomes. Given that infection often is the common pathway for delivery in preterm PROM, recent reports have explored the utility of maternal administration of antibiotics. In this paper we will summarize these results using meta- analytic techniques and assess the impact of antibiotic therapy on maternal and perinatal outcomes.

AB - The optimal management of preterm premature rupture of membranes (PROM) is controversial. Maternal risks must be weighed against fetal benefit when expectant management is considered. Despite concerns about maternal harm, protocols of expectant management seem to afford the best perinatal outcomes. Given that infection often is the common pathway for delivery in preterm PROM, recent reports have explored the utility of maternal administration of antibiotics. In this paper we will summarize these results using meta- analytic techniques and assess the impact of antibiotic therapy on maternal and perinatal outcomes.

UR - http://www.scopus.com/inward/record.url?scp=0029871504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029871504&partnerID=8YFLogxK

U2 - 10.1097/00006254-199605000-00024

DO - 10.1097/00006254-199605000-00024

M3 - Article

C2 - 8744417

AN - SCOPUS:0029871504

VL - 51

SP - 324

EP - 328

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

SN - 0029-7828

IS - 5

ER -